This paper presents an investor's comparative analysis of CVS Health and Walgreens, evaluating which company offers the stronger investment opportunity. Drawing on key financial ratios — including price-to-earnings, dividend payout ratio, debt-to-equity, and return on equity — the analysis argues in favor of CVS based on its lower earnings multiple, more sustainable dividend policy, and greater capacity to retain earnings. The paper also examines non-financial criteria, including management candor and the durability of each company's economic moat, with particular attention to competitive pressures exposed during the COVID-19 pandemic. A financial ratio appendix supports the conclusions drawn throughout.
When evaluating two competing investment options in the pharmacy retail sector, a thorough review of both financial metrics and qualitative factors is essential. Based on a review of each company's financial ratios and annual report disclosures, CVS Health presents the stronger investment case relative to Walgreens. The rationale for this conclusion is developed across financial and non-financial dimensions below.
CVS is currently trading at a lower earnings multiple than Walgreens, meaning the investor obtains more value per dollar of earnings relative to Walgreens. With a price-to-earnings ratio of 10 compared to Walgreens' 12, CVS offers a more attractive entry point, particularly in a low interest rate environment in which many stocks trade at historically elevated P/E multiples.
That said, the relatively low multiples at which both companies trade may warrant some concern. Even during a bull market, depressed valuations can indicate that the market is pricing in lower future earnings for both businesses — a signal of potential operational headwinds that should be monitored carefully.
CVS carries a significantly lower dividend payout ratio than Walgreens — 29% compared to 300%, respectively. This lower ratio provides greater security to investors regarding the company's ability to sustain future dividend payments. It also means CVS retains a larger portion of its earnings within the business, which can be used to strengthen the balance sheet through cash accumulation or reinvestment in operations.
By contrast, Walgreens paid out nearly three times its earnings in dividends, a level that is clearly unsustainable over the long term. It appears that Walgreens suffered materially from adverse business conditions during the COVID-19 pandemic and was reluctant to reduce its dividend for fear that investors would interpret such a cut as a lack of confidence in the company's future prospects. Maintaining an unaffordable dividend in hopes of a business recovery carries meaningful risk. If any unforeseen event further pressures the business, Walgreens will almost certainly need to reduce its dividend, which could trigger a sharp negative reaction from the market.
"CVS debt justified by low rates and retained earnings"
"Candor, moat durability, and COVID competitive pressures"
"Side-by-side ratio table for both companies"
Always verify citation format against your institution’s current style guide requirements.